GlyCLICK: From Research Tool to Enabling Technology for ADC Production

• Showcasing GlyCLICK site-specific conjugation, which delivers homogeneous ADCs with a defined DAR across many different antibody formats and payloads
• Following the technology's development beyond bench-scale research and towards large-scale bioconjugation
• Illustrating case studies and preclinical examples to bring to life how GlyCLICK supports ADC development 

Speakers:

Alexander Doyle

Global Business Development Manager

Genovis